Cell Biosciences Completes Acquisition of Alpha Innotech
October 28 2009 - 4:30PM
PR Newswire (US)
SANTA CLARA, Calif., Oct. 28 /PRNewswire/ -- Cell Biosciences, Inc.
today announced that it has completed its acquisition of Alpha
Innotech Corp. (OTC Bulletin Board: APNO). The stockholders of
Alpha Innotech have approved the transaction, and all regulatory
and other conditions have been satisfied. Pursuant to the merger
agreement announced on September 8, 2009, former Alpha Innotech
stockholders will receive $1.50 per share, or approximately $17.9
million in cash. ABOUT CELL BIOSCIENCES Cell Biosciences is a
private life sciences company focused on nanoproteomics. The
Company develops instrumentation systems, software, and assay
products that reveal previously undetectable information about
cellular control pathways. Its customers include leading
institutions in the fields of cancer research, stem cell biology,
and diabetes. Cell Biosciences' products enable researchers to
uncover fundamental mechanisms controlling cell proliferation and
cell death, to accelerate the development of new therapeutics, and
to help identify new prognostic and diagnostic disease biomarkers.
Cell Biosciences is located in Santa Clara, California. For more
information, visit http://www.cellbiosciences.com/. DATASOURCE:
Cell Biosciences, Inc. CONTACT: Tim Harkness, CEO of Cell
Biosciences, Inc., +1-408-510-5501, Web Site:
http://www.cellbiosciences.com/
Copyright